A Question of Scale | GenomeWeb

A Question of Scale

Premium

This will come as a shock to absolutely nobody, but I'm going to say it anyway: there's nothing straightforward about intellectual property issues. A recent can of worms came in the form of a presentation at a National Academy of Science committee attempting to get to the bottom of gene and protein patents and what kind of impact they have on medicine and research. Debra Leonard, vice chair of laboratory medicine in the department of pathology and laboratory medicine at Weill Medical College of Cornell University, gave a compelling presentation against the current status of gene patents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.